Search images on Google Product Monograph
Active Ingredients:
- famtozinameran, 15 MCG/0.3 ML
- tozinameran, 15 MCG/0.3 ML
DIN: 02531461
Dosage Form(s): SUSPENSION
Route(s) of Administration: INTRAMUSCULAR
Description: 2.25 ML MULTIDOSE VIAL AND 0.48ML SINGLE USE VIAL
Schedule: Schedule D
Company: BIONTECH MANUFACTURING GMBH
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07B - VIRAL VACCINES (ATC, WHO)
- J07BN - (ATC, WHO)
- J07BN01 - COVID-19, RNA-BASED VACCINE (WHO)